DBV Technologies (DBVT) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -75.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.65% |
| Dec 31, 2025 | -94.78% |
| Sep 30, 2025 | -8.94% |
| Jun 30, 2025 | -26.45% |
| Mar 31, 2025 | 0.90% |
| Dec 31, 2024 | -105.75% |
| Sep 30, 2024 | -81.90% |
| Jun 30, 2024 | -36.60% |
| Mar 31, 2024 | -32.99% |
| Dec 31, 2023 | 71.49% |
| Sep 30, 2023 | 3.19% |
| Jun 30, 2023 | -5.23% |
| Mar 31, 2023 | -23.08% |
| Dec 31, 2022 | -187.02% |
| Sep 30, 2022 | 28.07% |
| Jun 30, 2022 | 24.84% |
| Mar 31, 2022 | 43.27% |
| Dec 31, 2021 | 65.37% |
| Sep 30, 2021 | 22.36% |
| Mar 31, 2021 | 28.02% |
| Sep 30, 2020 | 76.43% |
| Sep 30, 2019 | -160.04% |
| Jun 30, 2016 | -249.14% |
| Dec 31, 2015 | -8.30% |
| Jun 30, 2015 | 1.66% |